Vanguard Global Advisers
GOSS icon

Vanguard Global Advisers’s Gossamer Bio GOSS Stock Holding History

Vanguard Global Advisers’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.1K Hold
79,682
– – ﹤0.01% 3427
2026
Q1 		$26.2K Buy
+79,682
New +$125K ﹤0.01% 3239

Other funds holding GOSS

D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.66% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $140M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return

Vanguard Global Advisers's GOSS Position: Q2 2026 in Review

Vanguard Global Advisers held its Gossamer Bio (GOSS) position steady in Q2 2026 at 79,682 shares worth $13.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3427.

Vanguard Global Advisers first reported a position in GOSS in Q1 2026 and has held it in 2 quarters since. The position peaked at $26.2K in Q1 2026. 155 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • Vanguard Global Advisers held 79,682 shares of Gossamer Bio worth $13.1K as of Q2 2026.
  • Vanguard Global Advisers left its Gossamer Bio share count unchanged in Q2 2026.
  • Gossamer Bio made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q2 2026, its #3427 holding.
  • Vanguard Global Advisers first reported a position in Gossamer Bio in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Global Advisers's Gossamer Bio position peaked at $26.2K in Q1 2026.
  • 155 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.